Magnetic Nanoworms and Nanocrystals Deliver siRNA to Tumors
Wednesday, September 23, 2009 - 18:21
in Biology & Nature
(PhysOrg.com) -- Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.